Computational Biology Market Size, Share & Trends Analysis Report By Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling), By Service, By End Use, And Segment Forecasts, 2022-2028

The global computational biology market size was valued at USD 2.9 billion in 2018 and is expected to witness a CAGR of 21.5% over the forecast period. Growing R&D for drug discovery, demand for predictive models, usage in population based sequencing projects such as human genome project, and government funding are the factors fueling market growth. For instance, in March 2019, Ambrx Inc., a clinical-stage biopharmaceutical company focused in the field of protein therapeutics signed R&D collaboration with BeiGene, Ltd., a commercial stage pharmaceutical company involved in the development of immuno-oncology drugs. Ambrx has proprietary Expanded Genetic Code platform designed to incorporate a non-natural amino acid into protein sequences of both E-coli and Chinese Hamster Ovary (CHO) cells. With this collaboration, both will leverage Ambrx’s drug discovery platforms with the latter’s knowledge expertise and resource pool for the development of clinically advanced biologics drugs.

Market Segmentation 

By Service Type 

• In-house
• Contract 

 By Application 

• Cellular & Biological Simulation
• Drug Discovery & Disease Modelling
• Preclinical Drug Development
• Pharmacokinetics
• Pharmacodynamics
• Clinical Trials
• Human Body Simulation Software
• Other

  By End Users

• Research
• Pharmaceutical Industry
• Commercial applications
• Others

Key Market Players

• Chemical Computing Group Inc.
• Compugen Ltd.
• Simulation Plus Inc.
• Genedata AG
• Certara
• Insilico Biotechnology AG
• Accelrys
• Rhenovia Pharma SAS
• Entelos
• Nimbus Discovery LLC
• Rhenovia Pharma SAS & Leadscope Inc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?